Weight loss (GLP-1)
Clinician-guided weight care with GLP-1 medications such as semaglutide and tirzepatide.
Treatment requires a consultation with a licensed provider. A prescription is not guaranteed — the provider decides what, if anything, is appropriate and safe for you.
About weight loss (glp-1)
GLP-1 (glucagon-like peptide-1) medications mimic a hormone your gut releases after eating. They slow how quickly your stomach empties and act on appetite signalling in the brain, so many people feel full sooner and think about food less. They were developed for type 2 diabetes and are now also used for weight management. Medication is one part of care: nutrition, movement, sleep, and follow-up all affect results, and results vary widely between individuals.
Treatment options
Plain-language summaries. Your provider decides what is appropriate for you.
Semaglutide
A once-weekly injection. Brand versions include Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management). Dosing is started low and increased gradually to limit side effects.
Tirzepatide
A once-weekly injection acting on two gut hormone receptors. Brand versions include Mounjaro (type 2 diabetes) and Zepbound (chronic weight management).
Oral adjuncts
For some people a GLP-1 is not appropriate or not affordable. Providers may discuss other prescription or non-prescription approaches where clinically suitable.
How it works
- 1
Share the basics
Tell us your state, the care you are interested in, and how to reach you.
- 2
Complete a medical visit
A licensed provider reviews your full health history through a secure clinical questionnaire and may request labs or a video visit.
- 3
Get a plan, if appropriate
If a provider prescribes, your medication ships from a licensed US pharmacy with dosing instructions.
- 4
Follow up
Regular check-ins to review tolerance, side effects, and whether the plan should change.
Realistic timeline
What people typically experience. Individual results vary and are never guaranteed.
- Weeks 1-4Starting dose. Appetite changes are often noticeable; GI side effects are most common in this window.
- Weeks 4-12Dose is stepped up gradually based on tolerance and response.
- Month 3+Providers typically reassess whether the medication is working and whether to continue, adjust, or stop.
Safety, side effects & interactions
You deserve this information before you decide, not after.
Common side effects
- Nausea, vomiting, diarrhea, or constipation — very common, especially after a dose increase
- Reflux, burping, abdominal discomfort
- Fatigue and headache
- Injection-site reactions
Serious risks
- Pancreatitis (severe, persistent abdominal pain — seek care immediately)
- Gallbladder problems, including gallstones
- Kidney injury from dehydration caused by prolonged vomiting or diarrhea
- Low blood sugar, particularly when combined with insulin or sulfonylureas
- In rodent studies these medicines caused thyroid C-cell tumors; the human risk is not established, and they carry a boxed warning
Interactions
- Insulin and sulfonylureas — may need dose changes to avoid hypoglycemia
- Oral medicines that depend on stomach emptying may be absorbed differently
Who this is — and isn't — for
May be a fit if
- Adults 18+
- Generally considered when BMI is 30+, or 27+ with a weight-related condition — your provider makes the determination
- Willing to attend follow-up check-ins
Not appropriate if
- Personal or family history of medullary thyroid carcinoma or MEN2
- History of pancreatitis (requires careful provider review)
- Pregnancy, trying to conceive, or breastfeeding
- Active eating disorder without treatment support
- Under 18
Pricing
Starting at, subject to provider evaluation. Actual medication and dose are determined clinically.
See all pricingCommon questions
Will I definitely be prescribed a GLP-1?
No. Treatment requires a consultation with a licensed provider, and a prescription is not guaranteed. The provider may recommend a different approach, request labs, or decline to prescribe if it is not safe or appropriate for you.
What is the difference between Ozempic, Wegovy, Mounjaro and Zepbound?
Ozempic and Wegovy are both semaglutide; Mounjaro and Zepbound are both tirzepatide. Within each pair the molecule is the same — the brands differ in the FDA-approved indication and dosing.
How much weight will I lose?
We do not promise a number. Published trials report a wide range of outcomes, and individual results depend on dose, tolerance, nutrition, activity, other medications, and health conditions. Some people lose little or stop because of side effects.
What happens if I stop?
Appetite effects fade after stopping, and weight regain is common. Your provider can discuss maintenance dosing or a structured taper with lifestyle support.
Is compounded medication the same thing?
Compounded preparations are made by licensed compounding pharmacies and are not FDA-approved products. They may be considered only where clinically appropriate and legally permitted, and your provider will explain the difference before prescribing.
Ready to see if this is right for you?
Start with a few basics — state, service, and how to reach you. The medical questionnaire is completed with a licensed provider.
Start your visitThis page is general health education, not medical advice, diagnosis, or treatment. It is not a substitute for care from your own clinician. If this is an emergency, call 911.